Orbitocranial resection for treatment of lacrimal gland malignant tumors with intracranial extension
OBJECTIVES: This study reports our experience with multidisciplinary surgical management of lacrimal gland malignant tumors with intracranial extension using the orbitocranial approach. METHODS: We reviewed treatment strategies and surgical approaches for lacrimal gland malignant tumors with intracranial extension and present 2 illustrative patients who underwent orbitocranial resection at our institution in 2015. Clinical records, radiographic images, histologic sections, and archived pathology specimens were reviewed. RESULTS: Both patients underwent orbitocranial tumor resection, followed by postoperative chemoradiotherapy. Orbital reconstruction was performed using a temporalis fascia flap and split calvarial bone grafts, with split-thickness skin grafting to line the orbital cavity. The follow-up periods were 69- and 66-months, respectively. Both patients remained alive without evidence of disease recurrence during follow-up. CONCLUSIONS: The orbitocranial approach, combined with postoperative chemoradiotherapy, may provide satisfactory local and regional control in selected patients with lacrimal gland malignant tumors with intracranial extension. Long-term surveillance remains important because patients may remain at risk for disease recurrence or distant metastasis.
Authors
- Pingan Wu (ORCID: https://orcid.org/0000-0003-4048-4276)
- Siyi Yang (ORCID: https://orcid.org/0009-0007-4810-1045)
- Wenfu Lu (ORCID: https://orcid.org/0009-0002-1482-9103)
- Yan Sui
- Ying Xia (ORCID: https://orcid.org/0009-0001-0408-805X)
- Guo-Chao Zhang (ORCID: https://orcid.org/0009-0000-4131-9198)
Institutions
- Shenzhen University (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Brazilian Journal of Otorhinolaryngology
- Published
- 2026-10-14
- DOI
- https://doi.org/10.1016/j.bjorl.2026.101921
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Hong Kong-Shenzhen Hospital